Amniotic and Placental Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
J15 · Effective Dec 10, 2023
18 active Medicare policies list Q4177, and 3 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
J15 · Effective Dec 10, 2023
J5 · Effective Nov 12, 2023
J8 · Effective Nov 12, 2023
J9 · Effective Dec 1, 2024
J6 · Effective Dec 24, 2023
JK · Effective Dec 24, 2023
JE · Effective Nov 12, 2023
JF · Effective Nov 12, 2023
3 policies from 3 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of Q4177 |
|---|---|---|
| Skin and Soft Tissue Substitutes | Not recorded | Covered |
| Policy | Effective | Status of Q4177 |
|---|---|---|
| Skin and Soft Tissue Substitutes | Aug 1, 2026 | Covered |
| Policy | Effective | Status of Q4177 |
|---|---|---|
| Skin and Soft Tissue Substitutes |
JH · Effective Dec 1, 2024
JL · Effective Dec 1, 2024
JJ · Effective Apr 30, 2023
JM · Effective Apr 30, 2023
National · Effective Oct 23, 2025
J6 · Effective Oct 1, 2025
National · Effective Oct 1, 2025
J5 · Effective Oct 1, 2025
J9 · Effective Jan 1, 2026
JL · Effective Jan 1, 2026
| Aug 1, 2026 |
| Covered |